Literature DB >> 24579802

PEG-PDLLA micelle treatment improves axonal function of the corpus callosum following traumatic brain injury.

Xingjie Ping1, Kewen Jiang, Seung-Young Lee, Ji-Xing Cheng, Xiaoming Jin.   

Abstract

The initial pathological changes of diffuse axonal injury following traumatic brain injury (TBI) include membrane disruption and loss of ionic homeostasis, which further lead to dysfunction of axonal conduction and axon disconnection. Resealing the axolemma is therefore a potential therapeutic strategy for the early treatment of TBI. Monomethoxy poly (ethylene glycol)-poly (D, L-lactic acid) di-block copolymer micelles (mPEG-PDLLA) have been shown to restore depressed compound action potentials (CAPs) of spinal axons and promote functional recovery after spinal cord injury. Here, we evaluate the effect of the micelles on repairing the injured cortical axons following TBI. Adult mice subjected to controlled cortical impact (CCI) were treated with intravenous injection of the micelles at 0 h or 4 h after injury. Evoked CAPs were recorded from the corpus callosum of coronal cortical slices at 2 days after injury. The CCI caused significant decreases in the amplitudes of two CAP peaks that were respectively generated by the faster myelinated axons and slower unmyelinated axons. Micelle treatment at both 0 h and 4 h after CCI resulted in significant increases in both CAP peak amplitudes. Injection of fluorescent dye-labeled micelles revealed high fluorescent staining in cortical gray and white matters underneath the impact site. Labeling membrane-perforated neurons by injecting a membrane impermeable dye Texas Red-labeled dextran into lateral ventricles at 2 h post-CCI revealed that immediate micelle injection after CCI did not reduce the number of dye-stained cortical neurons and dentate granule cells of the hippocampus, indicating its ineffectiveness in repairing plasma membrane of neuronal somata. We conclude that intravenous administration of mPEG-PDLLA micelles immediately or at 4 h after TBI allows brain penetration via the compromised blood brain-barrier, and thereby improves the function of both myelinated and unmyelinated axons of the corpus callosum.

Entities:  

Keywords:  CAP; TBI; axon; cerebral cortex; micelles

Mesh:

Substances:

Year:  2014        PMID: 24579802      PMCID: PMC4082361          DOI: 10.1089/neu.2013.3147

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  42 in total

1.  Myelinated and unmyelinated axons of the corpus callosum differ in vulnerability and functional recovery following traumatic brain injury.

Authors:  Thomas M Reeves; Linda L Phillips; John T Povlishock
Journal:  Exp Neurol       Date:  2005-08-18       Impact factor: 5.330

Review 2.  All roads lead to disconnection?--Traumatic axonal injury revisited.

Authors:  A Büki; J T Povlishock
Journal:  Acta Neurochir (Wien)       Date:  2005-12-20       Impact factor: 2.216

3.  A mouse model of blast injury to brain: initial pathological, neuropathological, and behavioral characterization.

Authors:  Vassilis E Koliatsos; Ibolja Cernak; Leyan Xu; Yeajin Song; Alena Savonenko; Barbara J Crain; Charles G Eberhart; Constantine E Frangakis; Tatiana Melnikova; Hyunsu Kim; Deidre Lee
Journal:  J Neuropathol Exp Neurol       Date:  2011-05       Impact factor: 3.685

4.  The effects of cyclosporin-A on axonal conduction deficits following traumatic brain injury in adult rats.

Authors:  Beverly S Colley; Linda L Phillips; Thomas M Reeves
Journal:  Exp Neurol       Date:  2010-04-01       Impact factor: 5.330

5.  Intracranial pressure changes during fluid percussion, controlled cortical impact and weight drop injury in rats.

Authors:  F Clausen; L Hillered
Journal:  Acta Neurochir (Wien)       Date:  2005-07       Impact factor: 2.216

6.  Mild traumatic brain injury results in extensive neuronal degeneration in the cerebral cortex.

Authors:  Xiang Gao; Jinhui Chen
Journal:  J Neuropathol Exp Neurol       Date:  2011-03       Impact factor: 3.685

7.  Surveillance for traumatic brain injury-related deaths--United States, 1997-2007.

Authors:  Victor G Coronado; Likang Xu; Sridhar V Basavaraju; Lisa C McGuire; Marlena M Wald; Mark D Faul; Bernardo R Guzman; John D Hemphill
Journal:  MMWR Surveill Summ       Date:  2011-05-06

Review 8.  Cognitive outcome in traumatic brain injury survivors.

Authors:  Claire Helen Salmond; Barbara Jacquelyn Sahakian
Journal:  Curr Opin Crit Care       Date:  2005-04       Impact factor: 3.687

9.  Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles.

Authors:  Yunzhou Shi; Sungwon Kim; Terry B Huff; Richard B Borgens; Kinam Park; Riyi Shi; Ji-Xin Cheng
Journal:  Nat Nanotechnol       Date:  2009-11-08       Impact factor: 39.213

10.  Mapping traumatic axonal injury using diffusion tensor imaging: correlations with functional outcome.

Authors:  Virginia Newcombe; Doris Chatfield; Joanne Outtrim; Sarah Vowler; Anne Manktelow; Justin Cross; Daniel Scoffings; Martin Coleman; Peter Hutchinson; Jonathan Coles; T Adrian Carpenter; John Pickard; Guy Williams; David Menon
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

View more
  8 in total

1.  The Positive Allosteric Modulator of α2/3-Containing GABAA Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury.

Authors:  Jeffrey M Witkin; Guanguan Li; Lalit K Golani; Wenhui Xiong; Jodi L Smith; Xingjie Ping; Farjana Rashid; Rajwana Jahan; Rok Cerne; James M Cook; Xiaoming Jin
Journal:  J Pharmacol Exp Ther       Date:  2019-11-06       Impact factor: 4.030

2.  Sex-Dependent Macromolecule and Nanoparticle Delivery in Experimental Brain Injury.

Authors:  Vimala N Bharadwaj; Connor Copeland; Ethan Mathew; Jason Newbern; Trent R Anderson; Jonathan Lifshitz; Vikram D Kodibagkar; Sarah E Stabenfeldt
Journal:  Tissue Eng Part A       Date:  2020-07       Impact factor: 3.845

3.  Blood-brainbarrier disruption dictates nanoparticle accumulation following experimental brain injury.

Authors:  Vimala N Bharadwaj; Rachel K Rowe; Jordan Harrison; Chen Wu; Trent R Anderson; Jonathan Lifshitz; P David Adelson; Vikram D Kodibagkar; Sarah E Stabenfeldt
Journal:  Nanomedicine       Date:  2018-06-19       Impact factor: 5.307

4.  CD157 in bone marrow mesenchymal stem cells mediates mitochondrial production and transfer to improve neuronal apoptosis and functional recovery after spinal cord injury.

Authors:  Jing Li; Heyangzi Li; Simin Cai; Shi Bai; Huabo Cai; Xiaoming Zhang
Journal:  Stem Cell Res Ther       Date:  2021-05-17       Impact factor: 6.832

5.  Membrane resealing as a promising strategy for early treatment of neurotrauma.

Authors:  Xiaoming Jin
Journal:  Neural Regen Res       Date:  2014-11-01       Impact factor: 5.135

6.  Temporal assessment of nanoparticle accumulation after experimental brain injury: Effect of particle size.

Authors:  Vimala N Bharadwaj; Jonathan Lifshitz; P David Adelson; Vikram D Kodibagkar; Sarah E Stabenfeldt
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

Review 7.  Traumatic Axonal Injury: Mechanisms and Translational Opportunities.

Authors:  Ciaran S Hill; Michael P Coleman; David K Menon
Journal:  Trends Neurosci       Date:  2016-03-31       Impact factor: 13.837

Review 8.  A Role for Nanoparticles in Treating Traumatic Brain Injury.

Authors:  Badrul Alam Bony; Forrest M Kievit
Journal:  Pharmaceutics       Date:  2019-09-13       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.